日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dual targeting of BRAF(V600E) and ferroptosis results in synergistic anticancer activity via iron overload and enhanced oxidative stress.

BRAF(V600E) 和铁死亡的双重靶向作用通过铁过载和增强氧化应激产生协同抗癌活性。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03624-z
Hu Jiangnan, Ghosh Chandrayee, Khaket Tejinder P, Yang Zhongyue, Tabdili Yasmine, Alamaw Eden D, Boufraqech Myriem, Dixon Scott J, Kebebew Electron
肿瘤
BRAF
氧化应激
铁死亡
发表日期：2026
文献求助 收藏

Corrigendum to "Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis" [Cancer Letters 633 (2025) 217990]

对“尼他唑尼和金诺芬联合治疗通过增强氧化应激的激活导致细胞凋亡，对间变性甲状腺癌具有协同抗癌活性”的更正[Cancer Letters 633 (2025) 217990]

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2025.218159
Ghosh, Chandrayee; Khaket, Tejinder Pal; Gunda, Viswanath; Yang, Zhongyue; Hu, Jiangnan; Alamaw, Eden Demissie; Zhang, Lisa; Zhang, Ya-Qin; Shen, Min; Tabdili, Yasmine; Boufraqech, Myriem; Kassu, Rodas; Kebebew, Electron
肿瘤
凋亡
表观遗传
肿瘤免疫
氧化应激
甲状腺癌
细胞生物学
毒理研究
免疫/内分泌
发表日期：2026
文献求助 收藏

Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer through enhanced activation of oxidative stress that leads to apoptosis.

硝唑尼特和金诺芬联合治疗对间变性甲状腺癌具有协同抗癌活性，其机制是通过增强氧化应激的激活，从而导致细胞凋亡。

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2025.217990
Ghosh Chandrayee, Khaket Tejinder Pal, Gunda Viswanath, Yang Zhongyue, Hu Jiangnan, Alamaw Eden Demissie, Zhang Lisa, Zhang Ya-Qin, Shen Min, Tabdili Yasmine, Boufraqech Myriem, Kassu Rodas, Kebebew Electron
甲状腺癌
细胞生物学
Apoptosis
凋亡
氧化应激
发表日期：2025
文献求助 收藏

Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice

二苯丁基哌啶类抗精神病药物通过抑制催乳素受体信号传导来减少小鼠胰腺导管腺癌的生长

期刊:Gastroenterology
影响因子:25.1
doi:10.1053/j.gastro.2019.11.279
Dandawate, Prasad; Kaushik, Gaurav; Ghosh, Chandrayee; Standing, David; Ali Sayed, Afreen Asif; Choudhury, Sonali; Subramaniam, Dharmalingam; Manzardo, Ann; Banerjee, Tuhina; Santra, Santimukul; Ramamoorthy, Prabhu; Butler, Merlin; Padhye, Subhash B; Baranda, Joaquina; Kasi, Anup; Sun, Weijing; Tawfik, Ossama; Coppola, Domenico; Malafa, Mokenge; Umar, Shahid; Soares, Michael J; Saha, Subhrajit; Weir, Scott J; Dhar, Animesh; Jensen, Roy A; Thomas, Sufi Mary; Anant, Shrikant
信号转导
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

A Combinatorial Strategy for Targeting BRAF (V600E)-Mutant Cancers with BRAF(V600E) Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib)

采用 BRAF (V600E) 抑制剂 (PLX4720) 和酪氨酸激酶抑制剂 (Ponatinib) 联合治疗 BRAF (V600E) 突变型癌症的联合策略

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-1606
Ghosh, Chandrayee; Kumar, Suresh; Kushchayeva, Yevgeniya; Gaskins, Kelli; Boufraqech, Myriem; Wei, Darmood; Gara, Sudheer Kumar; Zhang, Lisa; Zhang, Ya-Qin; Shen, Min; Mukherjee, Sanjit; Kebebew, Electron
信号转导
肿瘤
BRAF
肿瘤免疫
发表日期：2020
文献求助 收藏